Summarised consolidated statement of changes in equity
| R'000 | Year ended 30 June 2019 Audited |
Year ended 30 June 2018 Audited |
|||||
| Equity attributable to shareholders of the Company | 25 618 212 | 23 957 082 | |||||
| Share capital | 16 948 | 16 873 | |||||
| Balance at beginning of the year | 16 873 | 16 770 | |||||
| Shares issued during the year | 75 | 103 | |||||
| Share premium | 1 099 231 | 797 717 | |||||
| Balance at beginning of the year | 797 717 | 379 792 | |||||
| Shares issued during the year | 302 012 | 418 505 | |||||
| Share issue costs | (498) | (580) | |||||
| Foreign currency translation reserve | 208 936 | 262 787 | |||||
| Balance at beginning of the year | 262 787 | 286 628 | |||||
| Movement during the year | (10 948) | (23 168) | |||||
| Realisation of reserve on disposal of subsidiaries and or associates | (42 903) | (673) | |||||
| Hedging reserve | (13 580) | (963) | |||||
| Balance at beginning of the year | (963) | 6 489 | |||||
| Fair value losses arising during the year | (17 523) | (10 350) | |||||
| Deferred tax recognised directly in reserve | 4 906 | 2 898 | |||||
| Equity-settled share-based payment reserve | (343 118) | (243 388) | |||||
| Balance at beginning of the year | (243 388) | (14 787) | |||||
| Arising during the year | 191 070 | 155 637 | |||||
| Deferred tax recognised directly in reserve | 34 289 | 36 540 | |||||
| Utilisation during the year | (324 656) | (419 756) | |||||
| Realisation of reserve on disposal of subsidiaries and or associates | 8 049 | (1 022) | |||||
| Transfer of equity-settled share-based payment reserve as a result of changes in shareholding of subsidiaries | 2 734 | – | |||||
| Transfer from retained earnings | (11 216) | – | |||||
| Movement in retained earnings | 24 012 732 | 22 486 993 | |||||
| Balance at the beginning of the year | 22 486 993 | 20 279 261 | |||||
| IFRS 15 adjustment to balance at beginning of the period | (38 723) | – | |||||
| IFRS 9 adjustment to balance at beginning of the period | (41 360) | – | |||||
| Attributable profit | 3 775 282 | 3 817 996 | |||||
| Change in fair value of financial assets recognised through other comprehensive income | 23 849 | (3 111) | |||||
| Net remeasurement of defined benefit obligations during the year | (679) | 1 620 | |||||
| Retained earnings arising on consolidation of the Bidvest Education Trust | – | 222 155 | |||||
| Transfer of reserves as a result of changes in shareholding of subsidiaries and other transactions with subsidiaries | (218 674) | (85 706) | |||||
| Remeasurement of put option liability | (7 115) | (5 025) | |||||
| Share of other comprehensive income of associates | (13 828) | – | |||||
| Net dividends paid | (1 964 229) | (1 740 197) | |||||
| Transfer from equity-settled share-based payment reserve | 11 216 | – | |||||
| Treasury shares | 637 063 | 637 063 | |||||
| Balance at the beginning of the year | 637 063 | 743 152 | |||||
| Treasury shares arising on consolidation of the Bidvest Education Trust | – | (106 089) | |||||
| Equity attributable to non-controlling interests of the Company | 304 620 | 1 023 627 | |||||
| Balance at beginning of the year | 1 023 627 | 1 347 018 | |||||
| IFRS 15 adjustment to balance at beginning of the period | (14 506) | – | |||||
| IFRS 9 adjustment to balance at beginning of the period | (2 512) | – | |||||
| Other comprehensive income | 28 552 | 59 865 | |||||
| Attributable profit | 28 648 | 67 617 | |||||
| Movement in foreign currency translation reserve | (96) | (8 163) | |||||
| Net remeasurement of defined benefit obligations during the year | – | 411 | |||||
| Dividends paid | (51 207) | (319 984) | |||||
| Movement in equity-settled share-based payment reserve | (961) | (651) | |||||
| Transfer of equity-settled share-based payment reserve as a result of changes in shareholding of subsidiaries | (2 734) | – | |||||
| Changes in shareholding | (894 313) | (125 405) | |||||
| Grant of put options to non-controlling interests | – | (22 922) | |||||
| Transfer of reserves as a result of changes in shareholding of subsidiaries | 218 674 | 85 706 | |||||
| Total equity | 25 922 832 | 24 980 709 |